One of the key drivers for the growth of the worldwide Lung Cancer Therapeutics Market in 2018 is the rising adoption and demand for targeted therapies, which are thought to be the cornerstone of precision medicine due to the rising R&D activities. According to estimates, among the several therapeutic kinds, targeted therapy has the biggest market share. Targeted therapy has a market share of 51.1% in 2018 and is anticipated to grow over the course of the forecast period. The expansion of the targeted therapy market is also being driven by a growing emphasis on lung cancer detection and subsequent treatment based on precise targeting of the tumour or cancer source.
Read more @ https://creativeedge16.blogspot.com/2022/10/lung-cancer-therapeutics-market-report.html
